Endosomal transport of ErbB-2: Mechanism for nuclear entry of the cell surface receptor

Molecular and Cellular Biology

Volumn 25, Issue 24, 2005, Pages 11005-11018

  Giri, Dipak K ^a   Ali Seyed, Mohamed ^a   Li, Long Yuan ^a   Lee, Dung Fang ^a   Ling, Pin ^a   Bartholomeusz, Geoffrey ^a   Wang, Shao Chun ^a   Hung, Mien Chie ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; DYNAMIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GUANOSINE TRIPHOSPHATASE; KARYOPHERIN BETA; MUTANT PROTEIN; NUCLEOPORIN; OLIGONUCLEOTIDE; PROTEIN NUP358; PROTEIN TYROSINE KINASE; RAN PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELL SURFACE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; ENZYME INACTIVATION; HUMAN; HUMAN CELL; INTERNALIZATION; KNOCKOUT GENE; MUTATION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

ACTIVE TRANSPORT, CELL NUCLEUS; BETA KARYOPHERINS; CELL NUCLEUS; CELLS, CULTURED; CLATHRIN; ENDOCYTOSIS; ENDOSOMES; HUMANS; KARYOPHERINS; MOLECULAR CHAPERONES; MUTATION; NUCLEAR LOCALIZATION SIGNALS; NUCLEAR PORE COMPLEX PROTEINS; RAN GTP-BINDING PROTEIN; RECEPTOR, ERBB-2; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 28544448741     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.24.11005-11018.2005     Document Type: Article

References (57)

1. Bacus, S. S., E. Huberman, D. Chin, K. Kiguchi, S. Simpson, M. Lippman, and R. Lupu. 1992. A ligand for the erbB-2 oncogene product (GP30) induces differentiation of human breast cancer cells. Cell Growth Differ. 3:401-411.
2. Ben-Efraim, I., and L. Gerace. 2001. Gradient of increasing affinity of importin beta for nucleoporins along the pathway of nuclear import. J. Cell Biol. 152:411-417.
3. Benmerah, A., C. Lamaze, B. Begue, S. L. Schmid, A. Dautry-Varsat, and N. Cerf-Bensussan. 1998. AP-2/Eps15 interaction is required for receptor-mediated endocytosis. J. Cell Biol. 140:1055-1062.
4. Benz, C. C., G. K. Scott, J. C. Sarup, R. M. Johnson, D. Tripathy, E. Coronado, H. M. Shepard, and C. K. Osborne. 1993. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res. Treat. 24:85-95.
5. Bild, A. H., J. Turkson, and R. Jove. 2002. Cytoplasmic transport of Stat3 by receptor-mediated endocytosis. EMBO J. 21:3255-3263.
6. Cao, H., F. Garcia, and M. A. McNiven. 1998. Differential distribution of dynamin isoforms in mammalian cells. Mol. Biol. Cell 9:2595-2609.
7. Cao, H., H. M. Thompson, E. W. Krueger, and M. A. McNiven. 2000. Disruption of Golgi structure and function in mammalian cells expressing a mutant dynamin. J. Cell Sci. 113:1993-2002.
8. Carpenter, G. 2003. Nuclear localization and possible functions of receptor tyrosine kinases. Curr. Opin. Cell Biol. 15:143-148.
9. Chiu, V. K., T. Bivona, A. Hach, J. B. Sajous, J. Silletti, H. Wiener, R. L. Johnson II, A. D. Cox, and M. R. Philips. 2002. Ras signaling on the endoplasmic reticulum and the Golgi. Nat. Cell Biol. 4:343-350.
10. Coda, L., A. E. Salcini, S. Confalonieri, G. Pelicci, T. Sorkina, A. Sorkin, P. G. Pelicci, and P. P. Di Fiore. 1998. Eps15R is a tyrosine kinase substrate with characteristics of a docking protein possibly involved in coated pits-mediated internalization. J. Biol. Chem. 273:3003-3012.
11. Conner, S. D., and S. L. Schmid. 2003. Regulated portals of entry into the cell. Nature 422:37-44.
12. Doria, M., A. E. Salcini, E. Colombo, T. G. Parslow, P. G. Pelicci, and P. P. Di Fiore. 1999. The eps15 homology (EH) domain-based interaction between eps15 and hrb connects the molecular machinery of endocytosis to that of nucleocytosolic transport. J. Cell Biol. 147:1379-1384.
13. Feng, Y., V. J. Venema, R. C. Venema, N. Tsai, and R. B. Caldwell. 1999. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem. Biophys. Res. Commun. 256:192-197.
14. Freedman, D. A., and A. J. Levine. 1998. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol. 18:7288-7293.
15. Gorlich, D., and U. Kutay. 1999. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 15:607-660.
16. Graham, J. M., and D. Rickwood. 1997. Subcellular fractionation: a practical approach. IRL Press at Oxford University Press, Oxford, United Kingdom.
17. Hanada, N., H. W. Lo, C. P. Day, Y. Pan, Y. Nakajima, and M. C. Hung. Co-regulation of B-Myb expression by E2F1 and EGFR receptor. Mol. Carcinog., in press.
18. Holmes, W. E., M. X. Sliwkowski, R. W. Akita, W. J. Henzel, J. Lee, J. W. Park, D. Yansura, N. Abadi, H. Raab, G. D. Lewis, et al. 1992. Identification of heregulin, a specific activator of p185erbB2. Science 256:1205-1210.
19. Huang, T. T., N. Kudo, M. Yoshida, and S. Miyamoto. 2000. A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes. Proc. Natl. Acad. Sci. USA 97:1014-1019.
20. 2+ finger protein (PLZF). J. Cell Biol. 149:537-546.
21. Ilan, N., A. Tucker, and J. A. Madri. 2003. Vascular endothelial growth factor expression, beta-catenin tyrosine phosphorylation, and endothelial proliferative behavior: a pathway for transformation? Lab. Investig. 83:1105-1115.
22. Jiang, X., N. Takahashi, K. Ando, T. Otsuka, T. Tetsuka, and T. Okamoto. 2003. NF-κB p65 transactivation domain is involved in the NF-κB-inducing kinase pathway. Biochem. Biophys. Res. Commun. 301:583-590.
23. Johnston, C. L., H. C. Cox, J. J. Gomm, and R. C. Coombes. 1995. Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus. J. Biol. Chem. 270: 30643-30650.
24. Jurata, L. W., S. L. Pfaff, and G. N. Gill. 1998. The nuclear LIM domain interactor NLI mediates homo- and heterodimerization of LIM domain transcription factors. J. Biol. Chem. 273:3152-3157.
25. Kudo, N., N. Matsumori, H. Taoka, D. Fujiwara, E. P. Schreiner, B. Wolff, M. Yoshida, and S. Horinouchi. 1999. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci. USA 96:9112-9117.
26. Levitzki, A., and A. Gazit. 1995. Tyrosine kinase inhibition: an approach to drug development. Science 267:1782-1788.
27. Lin, S. Y., K. Makino, W. Xia, A. Matin, Y. Wen, K. Y. Kwong, L. Bourguignon, and M. C. Hung. 2001. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. Cell Biol. 3:802-808.
28. Lo, H. W., S. C. Hsu, M. Ali-Seyed, M. Gunduz, W. Xia, Y. Wei, G. Bartholomeusz, J. Y. Shih, and M. C. Hung. 2005. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7:575-589.
29. Lo, H. W., W. Xia, Y. Wei, M. Ali-Seyed, S. F. Huang, and M. C. Hung. 2005. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res. 65:338-348.
30. Macara, I. G. 2001. Transport into and out of the nucleus. Microbiol. Mol. Biol. Rev. 65:570-594.
31. Maher, P. A. 1996. Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J. Cell Biol. 134:529-536.
32. Marti, U., and A. Wells. 2000. The nuclear accumulation of a variant epidermal growth factor receptor (EGFR) lacking the transmembrane domain requires coexpression of a full-length EGFR. Mol. Cell Biol. Res. Commun. 3:8-14.
33. Mattaj, I. W., and L. Englmeier. 1998. Nucleocytoplasmic transport: the soluble phase. Annu. Rev. Biochem. 67:265-306.
34. Mayo, L. D., K. M. Kessler, R. Pincheira, R. S. Warren, and D. B. Donner. 2001. Vascular endothelial cell growth factor activates CRE-binding protein by signaling through the KDR receptor tyrosine kinase. J. Biol. Chem. 276:25184-25189.
35. Nachury, M. V., T. J. Maresca, W. C. Salmon, C. M. Waterman-Storer, R. Heald, and K. Weis. 2001. Importin beta is a mitotic target of the small GTPase Ran in spindle assembly. Cell 104:95-106.
36. Ni, C. Y., M. P. Murphy, T. E. Golde, and G. Carpenter. 2001. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294:2179-2181.
37. Offterdinger, M., C. Schofer, K. Weipoltshammer, and T. W. Grunt. 2002. c-erbB-3: a nuclear protein in mammary epithelial cells. J. Cell Biol. 157: 929-939.
38. Peng, H., J. Moffett, J. Myers, X. Fang, E. K. Stachowiak, P. Maher, E. Kratz, J. Hines, S. J. Fluharty, E. Mizukoshi, D. C. Bloom, and M. K. Stachowiak. 2001. Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Mol. Biol. Cell 12:449-462.
39. Rao, V. N., and E. S. Reddy. 1993. Elk-1 proteins are phosphoproteins and activators of mitogen-activated protein kinase. Cancer Res. 53:3449-3454.
40. Reilly, J. F., and P. A. Maher. 2001. Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation. J. Cell Biol. 152:1307-1312.
41. Seol, K. C., and S. J. Kim. 2003. Nuclear matrix association of insulin receptor and IRS-1 by insulin in osteoblast-like UMR-106 cells. Biochem. Biophys. Res. Commun. 306:898-904.
42. Sever, S. 2002. Dynamin and endocytosis. Curr. Opin. Cell Biol. 14:463-467.
43. Stachowiak, E. K., X. Fang, J. Myers, S. Dunham, and M. K. Stachowiak. 2003. cAMP-induced differentiation of human neuronal progenitor cells is mediated by nuclear fibroblast growth factor receptor-1 (FGFR1). J. Neurochem. 84:1296-1312.
44. Stachowiak, E. K., P. A. Maher, J. Tucholski, E. Mordechal, A. Joy, J. Moffett, S. Coons, and M. K. Stachowiak. 1997. Nuclear accumulation of fibroblast growth factor receptors in human glial cells-association with cell proliferation. Oncogene 14:2201-2211.
45. Stachowiak, M. K., P. A. Maher, A. Joy, E. Mordechal, and E. K. Stachowiak. 1996. Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells. Mol. Biol. Cell 7:1299-1317.
46. Strom, A. C., and K. Weis. 2001. Importin-beta-like nuclear transport receptors. Genome Biol. 2:3008.1-3008.9.
47. Suntharalingam, M., and S. R. Wente. 2003. Peering through the pore: nuclear pore complex structure, assembly, and function. Dev. Cell 4:775-789.
48. Vecchi, M., S. Polo, V. Poupon, J. W. van de Loo, A. Benmerah, and P. P. Di Fiore. 2001. Nucleocytoplasmic shuttling of endocytic proteins. J. Cell Biol. 153:1511-1517.
49. Wang, S. C., H. C. Lien, W. Xia, I. F. Chen, H. W. Lo, Z. Wang, M. Ali-Seyed, D. F. Lee, G. Bartholomeusz, F. Ou-Yang, D. K. Giri, and M. C. Hung. 2004. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6:251-261.
50. Weis, K. 2002. Nucleocytoplasmic transport: cargo trafficking across the border. Curr. Opin. Cell Biol. 14:328-335.
51. Weis, K. 2003. Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle. Cell 112:441-451.
52. Wells, A., and U. Marti. 2002. Signalling shortcuts: cell-surface receptors in the nucleus? Nat. Rev. Mol. Cell Biol. 3:697-702.
53. Wu, J., M. J. Matunis, D. Kraemer, G. Blobel, and E. Coutavas. 1995. Nup358, a cytoplasmically exposed nucleoporin with peptide repeats, Ran-GTP binding sites, zinc fingers, a cyclophilin A homologous domain, and a leucine-rich region. J. Biol. Chem. 270:14209-14213.
54. Xie, Y., and M. C. Hung. 1994. Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation. Biochem. Biophys. Res. Commun. 203:1589-1598.
55. Yang, J., E. S. Bardes, J. D. Moore, J. Brennan, M. A. Powers, and S. Kornbluth. 1998. Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1. Genes Dev. 12:2131-2143.
56. Yokoyama, N., N. Hayashi, T. Seki, N. Pante, T. Ohba, K. Nishii, K. Kuma, T. Hayashida, T. Miyata, U. Aebi, et al. 1995. A giant nucleopore protein that binds Ran/TC4. Nature 376:184-188.
57. Zammit, C., R. Barnard, J. Gomm, R. Coope, S. Shousha, C. Coombes, and C. Johnston. 2001. Altered intracellular localization of fibroblast growth factor receptor 3 in human breast cancer. J. Pathol. 194:27-34.